Tumour imaging by the detection of fibrin clots in tumour stroma using an anti-fibrin Fab fragment

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Obonai, Toshifumi ^a,b   Fuchigami, Hirobumi ^a,b   Furuya, Fumiaki ^a   Kozuka, Naoyuki ^a,b   Yasunaga, Masahiro ^a,b   Matsumura, Yasuhiro ^a,b  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; MONOCLONAL ANTIBODY;

ANIMAL; CARCINOMA, PANCREATIC DUCTAL; EARLY CANCER DIAGNOSIS; EXPERIMENTAL NEOPLASM; GENETIC ENGINEERING; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; MUTATION; PANCREAS TUMOR; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, PANCREATIC DUCTAL; EARLY DETECTION OF CANCER; FIBRIN; GENETIC ENGINEERING; HUMANS; MICE; MUTATION; NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84962233522     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23613     Document Type: Article

References (46)

1. Bill-Axelson, A. et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 364, 1708-17 (2011).
2. Weisel, J. W. Fibrinogen and fibrin. Adv Protein Chem 70, 247-99 (2005).
3. Silvain, J. et al. Composition of coronary thrombus in acute myocardial infarction. J Am Coll Cardiol 57, 1359-67 (2011).
4. Skaf, E. et al. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol 96, 1731-3 (2005).
5. Drew, A. F., Liu, H., Davidson, J. M., Daugherty, C. C. & Degen, J. L. Wound-healing defects in mice lacking fibrinogen. Blood 97, 3691-8 (2001).
6. Levi, M., Van Der Poll, T. & Buller, H. R. Bidirectional relation between inflammation and coagulation. Circulation 109, 2698-704 (2004).
7. Idell, S. et al. Regulation of fibrin deposition by malignant mesothelioma. Am J Pathol 147, 1318-29 (1995).
8. Im, J. H. et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 64, 8613-9 (2004).
9. Matsumura, Y., Kimura, M., Yamamoto, T. & Maeda, H. Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue. Jpn J Cancer Res 79, 1327-34 (1988).
10. Dvorak, H. F. Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20, 4368-80 (2002).
11. Hisada, Y. et al. Discovery of an uncovered region in fibrin clots and its clinical significance. Sci Rep 3, 2604 (2013).
12. Colpaert, C. G. et al. Cutaneous breast cancer deposits show distinct growth patterns with different degrees of angiogenesis, hypoxia and fibrin deposition. Histopathology 42, 530-40 (2003).
13. Shoji, M. et al. Activation of coagulation and angiogenesis in cancer: Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol 152, 399-411 (1998).
14. Nagy, J. A., Dvorak, A. M. & Dvorak, H. F. Vascular hyperpermeability, angiogenesis, and stroma generation. Cold Spring Harb Perspect Med 2, a006544 (2012).
15. Matsumura, Y. Cancer stromal targeting (CAST) therapy. Adv Drug Deliv Rev 64, 710-9 (2012).
16. Dvorak, H. F. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315, 1650-9 (1986).
17. Van Den Berg, Y. W., Osanto, S., Reitsma, P. H. & Versteeg, H. H. The relationship between tissue factor and cancer progression: Insights from bench and bedside. Blood 119, 924-32 (2012).
18. Seto, S. et al. Tissue factor expression in human colorectal carcinoma: Correlation with hepatic metastasis and impact on prognosis. Cancer 88, 295-301 (2000).
19. Ueno, T., Toi, M., Koike, M., Nakamura, S. & Tominaga, T. Tissue factor expression in breast cancer tissues: Its correlation with prognosis and plasma concentration. Br J Cancer 83, 164-70 (2000).
20. Nitori, N. et al. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. Clin Cancer Res 11, 2531-9 (2005).
21. Kudryk, B., Rohoza, A., Ahadi, M., Chin, J. & Wiebe, M. E. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. Mol Immunol 21, 89-94 (1984).
22. Rosebrough, S. F. et al. Aged venous thrombi: Radioimmunoimaging with fibrin-specific monoclonal antibody. Radiology 162, 575-7 (1987).
23. Gargan, P. E., Gaffney, P. J., Pleasants, J. R. & Ploplis, V. A. A monoclonal antibody which recognises an epitopic region unique to the intact fibrin polymeric structure. Fibrinolysis 7, 275-283 (1993).
24. Freise, A. C. & Wu, A. M. In vivo imaging with antibodies and engineered fragments. Mol Immunol 67, 142-52 (2015).
25. Warram, J. M. et al. Antibody-based imaging strategies for cancer. Cancer Metastasis Rev 33, 809-22 (2014).
26. Kaur, S. et al. Recent trends in antibody-based oncologic imaging. Cancer Lett 315, 97-111 (2012).
27. Wu, A. M. Engineered antibodies for molecular imaging of cancer. Methods 65, 139-47 (2014).
28. Wartha, K., Herting, F. & Hasmann, M. Fit-for purpose use of mouse models to improve predictivity of cancer therapeutics evaluation. Pharmacol Ther 142, 351-361 (2014).
29. Guerra, C. & Barbacid, M. Genetically engineered mouse models of pancreatic adenocarcinoma. Mol Oncol 7, 232-47 (2013).
30. Li, H. & Edlund, H. Persistent expression of Hlxb9 in the pancreatic epithelium impairs pancreatic development. Dev Biol 240, 247-53 (2001).
31. Tewari, N. et al. The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: An immunohistochemical study of tissue microarrays. BMC Cancer 13, 436 (2013).
32. Massoud, T. F. & Gambhir, S. S. Molecular imaging in living subjects: Seeing fundamental biological processes in a new light. Genes Dev 17, 545-80 (2003).
33. Weisel, J. W. & Litvinov, R. I. Mechanisms of fibrin polymerization and clinical implications. Blood 121, 1712-9 (2013).
34. Kim, P. Y., Stewart, R. J., Lipson, S. M. & Nesheim, M. E. The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease. J Thromb Haemost 5, 1250-6 (2007).
35. Zamolodchikov, D. & Strickland, S. Abeta delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin. Blood 119, 3342-51 (2012).
36. Doolittle, R. F. & Pandi, L. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini. Biochemistry 46, 10033-8 (2007).
37. Pandi, L. et al. Two families of synthetic peptides that enhance fibrin turbidity and delay fibrinolysis by different mechanisms. Biochemistry 48, 7201-8 (2009).
38. Wyseure, T. & Declerck, P. J. Novel or expanding current targets in fibrinolysis. Drug Discov Today 19, 1476-82 (2014).
39. Lugovskoy, E. V., Gritsenko, P. G., Kolesnikova, I. N., Lugovskaya, N. E. & Komisarenko, S. V. A neoantigenic determinant in coiled coil region of human fibrin beta-chain. Thromb Res 123, 765-70 (2009).
40. Putelli, A., Kiefer, J. D., Zadory, M., Matasci, M. & Neri, D. A fibrin-specific monoclonal antibody from a designed phage display library inhibits clot formation and localizes to tumors in vivo. J Mol Biol 426, 3606-18 (2014).
41. Versteeg, H. H. et al. Inhibition of tissue factor signaling suppresses tumor growth. Blood 111, 190-9 (2008).
42. Morrow, D. A. et al. Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): Results of the PROXIMATE-TIMI 27 trial. Eur Heart J 26, 682-8 (2005).
43. Morris, P. E. et al. A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome. BMC Pulm Med 12, 5 (2012).
44. Yasunaga, M., Manabe, S. & Matsumura, Y. New concept of cytotoxic immunoconjugate therapy targeting cancer-induced fibrin clots. Cancer Sci 102, 1396-402 (2011).
45. Goodall, A. H. & Appleby, J. Flow-cytometric analysis of platelet-membrane glycoprotein expression and platelet activation. Methods Mol Biol 272, 225-53 (2004).
46. Kawaguchi, Y. et al. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet 32, 128-34 (2002).